Credo: The Market Is In Disbelief, But You Shouldn't Be Fooled

Credo Technology remains on the buy list despite a sharp post-earnings de-rating and skepticism over optical revenue. The stock is down to a 22.5x earnings multiple, while management reaffirmed >85% growth in the fiscal year and stated there is no near-term disruption between its AEC and optical businesses. Key debate points are hyperscaler concentration (>60%), the risk of CapEx slowing after FY2028, and whether the $600M optical revenue guidance is robust.

Analysis

The market is probably collapsing two different risks into one valuation: customer concentration and a presumed product-cycle peak. If CRDO is still compounding earnings at a high rate, a low-20s multiple implies investors are discounting a sharp step-down that is not yet visible in order flow; that setup often means the downside is driven by narrative, not fundamentals, until the next proof point. The more important question is whether AEC and optical are competing or widening the addressable wallet at the same hyperscalers — if it is the latter, then the bear case is overstating substitution risk and understating account-level share gains.

The real downside catalyst is not the FY2028 capex debate; it is a near-term pause in one or two hyperscaler budgets that would hit sequential growth before the market can re-rate the stock. Because revenue is concentrated, CRDO can de-rate faster than its fundamentals deteriorate, but that also means any single large customer reaffirmation can force a violent squeeze higher. Watch for revisions to AI networking budgets, not generic semiconductor demand, because the stock will trade more on capex commentary than on broad sector PMIs.

Contrarian view: consensus is likely anchoring on the guidance number without stress-testing what the business mix is doing to gross margin durability and operating leverage. If optical revenue is real, the multiple should not stay where a slower-growth interconnect supplier would trade; if it is not, the stock can drift into a value trap as investors demand proof that the growth rate is repeatable. The falsifier is simple: any sequential slowdown in bookings or a softer hyperscaler capex read-through in the next 1-2 quarters would invalidate the re-rating thesis.

Key Decisions for Investors

• Initiate a starter long CRDO position on further weakness, sized for high volatility; base case is a 3-6 month re-rating if sequential orders stay intact and hyperscaler capex commentary remains constructive.
• Use a CRDO call spread rather than outright stock if implied vol stays elevated; the setup is a catalyst-driven squeeze, but the concentration risk argues for defined downside.
• Pair trade: long CRDO / short a broader optical or network-gear proxy such as CIEN or MRVL for 1-3 months if you want to isolate the company-specific re-rating from sector beta.
• Set a stop/alert on any evidence of customer spending deferral in the next quarterly update; a single major cloud customer delay would likely break the thesis and could push the stock toward a lower-teens earnings multiple.
• If management confirms that AEC and optical are both scaling without cannibalization, add on strength rather than chasing upfront — that would be the highest-conviction signal for a 6-12 month multiple expansion.